期刊文献+

心血管疾病中监测抗血小板药物指标的研究进展 被引量:5

下载PDF
导出
摘要 阿司匹林是至今发现的活性最强的内源性血小板抑制剂之一,能抑制二磷酸腺苷(ADP)胶原等诱导的血小板聚集和释放。心血管疾病多使用阿司匹林等抗血小板药物进行抗栓治疗,其传统监测指标主要依赖测定血小板聚集性的高低来进行药物剂量的调整。由于近年来治疗手段的不断提高,氯吡格雷、普拉格雷、西洛他唑等不同作用机制抗血小板药不断问世。
出处 《中国老年学杂志》 CAS CSCD 北大核心 2012年第22期5100-5102,共3页 Chinese Journal of Gerontology
  • 相关文献

参考文献20

  • 1Tousoulis D,Antoniades C,Nikolopoulou A,et al.Interaction between cy-tokines and sCD40L in patients with stable and unstable coronary syn-dromes[J].Eur J Clin Invest,2007;37(8):623-8.
  • 2Welt FG,Rogers SD,Zhang X,et al.GPⅡb/Ⅲa inhibition with eptifibatide lowers levels of soluble CD40L and RANTES after percutaneous coronary intervention[J].Catheter Cardiovasc Interv,2004;61(2):185-9.
  • 3Obradovic SD,Antovic JP,Antonijevic NM,et al.Elevations in soluble CD40 ligand in patients with high platelet aggregability undergoing percu-taneous coronary intervention[J].Blood Coagul Fibrinolysis,2009;20(4):283-9.
  • 4Yip HK,Chang LT,Sun CK,et al.Impact of clopidogrel on suppression of circulating levels of soluble CD40 ligand in patients with unstable angina undergoing coronary stenting[J].Am J Cardiol,2006;97(2):192-4.
  • 5Azar RR,Kassab R,Zoghbi A,et al.Effects of clopidogrel on soluble CD40 ligand and on high-sensitivity C-reactive protein in patients with stable coronary artery disease[J].Am Heart J,2006;151(2):521.
  • 6Riondino S,Martini F,La Farina F,et al.Increased plasma levels of solu-ble CD40 ligand correlate with platelet activation markers and underline the need for standardized pre-analytical conditions[J].Clin Biochem,2010;43(7-8):666-70.
  • 7Derosa G,D'Angelo A,Scalise F,et al.Comparison between metallopro-teinases-2 and-9 in healthy subjects,diabetics,and subjects with acute coronary syndrome[J].Heart Vessels,2007;22(6):361-70.
  • 8Hua Y,Xue J,Sun F,et al.Aspirin inhibits MMP-2 and MMP-9 expres-sions and activities through upregulation of PPARalpha/gamma and TIMP gene expressions in ox-LDL-stimulated macrophages derived from human monocytes[J].Pharmacology,2009;83(1):18-25.
  • 9孟晓萍,王素香,张基昌,李震霄,耿丽,殷春媛.普罗布考联合降脂药物对动脉粥样硬化病人的干预治疗[J].中华医学杂志,2009,89(28):1986-1988. 被引量:37
  • 10Lu L,Liu H,Peng J,et al.Regulations of the key mediators in inflamma-tion and atherosclerosis by aspirin in human macrophages[J].Lipids Health Dis,2010;9:16-23.

二级参考文献14

共引文献45

同被引文献43

  • 1刘兆平.阿司匹林在心血管疾病预防中的地位:阿司匹林抵抗的影响[J].中国医学前沿杂志(电子版),2008(1):48-51. 被引量:1
  • 2武艺.心血管疾病血小板糖蛋白Ⅱb/Ⅲa受体的研究进展[J].国外医学(心血管疾病分册),1996,23(3):151-153. 被引量:5
  • 3蒙碧波,吕传柱,蒋宜颖.直接凝血酶抑制剂及其在心血管疾病中的应用[J].中国心血管病研究,2006,4(1):72-75. 被引量:30
  • 4A H Gershlick,G Richardson,李崇剑(译),高润霖(校).药物洗脱支架 中断双重抗血小板药物治疗前应咨询心血管病专家[J].英国医学杂志中文版,2007,10(2):73-74. 被引量:1
  • 5Torbicki A, Perrier A, Konstantinides S. Guidelines on the diagno- sis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology ( ESC ) [ J ]. Eur Heart J, 2008,29 ( 11 ) :2276-2315.
  • 6Meneveau N, Ming LP, Seronde MF, et al. In hospital and long term outcome after sub-massive and massive pulmonary embolism submitted to thrombolytic therapy [ J ]. Eur Heart J, 2013,24 ( 5 ) : 1447-1454.
  • 7Goldhaber SZ, Visani L, De Rosa M, et al. Acute pulmonary em- bolism:clinical outcomes in the International Cooperative Pulmo- nary Embolism Registry(ICOPER) [ J]. Lancet,2011,353 ( 12 ) : 1386-1389.
  • 8Giannitsis E, Muller-Bardoeff M, Kurowski V, ct al. Independent prognostic value of cardiac tropnin T in patients with confirmed pulmonary embolism [ J ]. Circulation,2010,102 (5) :211-217.
  • 9陈灏珠,钟南山,陆再英主编.内科学.第8版.北京:人民卫生出版社,2013.524.
  • 10van den Born B J, lwenberg E C, van der Hoeven N V,et al.Endothelial dysfunction, platelet activation, thrombogenesis and fibrinolysis in patients with hypertensivecrisis. J Hypertens,2011,29 (5) :922-927.

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部